(19)
(11) EP 4 114 983 A1

(12)

(43) Date of publication:
11.01.2023 Bulletin 2023/02

(21) Application number: 21710267.2

(22) Date of filing: 05.03.2021
(51) International Patent Classification (IPC): 
C12Q 1/6886(2018.01)
C12Q 1/689(2018.01)
(52) Cooperative Patent Classification (CPC):
C12Q 1/6886; C12Q 2600/106; C12Q 1/689
(86) International application number:
PCT/EP2021/055556
(87) International publication number:
WO 2021/176036 (10.09.2021 Gazette 2021/36)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 06.03.2020 US 202062986063 P

(71) Applicants:
  • Leibniz-Institut für Naturstoff-Forschung und Infektionsbiologie e.V. -Hans-Knöll-Institut- (HKI)
    07745 Jena (DE)
  • Danmarks Tekniske Universitet
    2800 Kongens Lyngby (DK)

(72) Inventors:
  • PANAGIOTOU, Gianni
    10405 Berlin (DE)
  • HESHIKI, Yoshitaro
    Tokyo, 155--0033 (JP)
  • VAZQUEZ-URIBE, Ruben
    1855 Frederiksberg (DK)
  • QUAINOO, Scott
    2100 København (DK)
  • SOMMER, Morten, Otto, Alexander
    2900 Hellerup (DK)
  • WEISS, Glen
    Boston, Massachusetts 02111 (US)

(74) Representative: Krauss, Jan 
Boehmert & Boehmert Anwaltspartnerschaft mbB Pettenkoferstrasse 22
80336 München
80336 München (DE)

   


(54) METHOD FOR THE MODULATION OF CANCER TREATMENT BASED ON ANALYZING THE GUT MICROBIOME